Evaluation of Induction Immunosuppression in Elderly Kidney Transplant Recipients.

被引：0
|
作者：
Pham, C. [1 ]
Kuten, S. [1 ]
Rogers, A. [1 ]
Knight, R. [1 ]
Nguyen, D. T. [1 ]
Graviss, E. [1 ]
Gaber, A. [1 ]
机构：
[1] Houston Methodist Hosp, Houston, TX USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2019年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B207
引用
收藏
页码：824 / 824
页数：1
相关论文
共 50 条
  • [1] Optimizing immunosuppression for elderly kidney transplant recipients.
    Takemoto, Steven K.
    Mendez, Robert
    Mendez, Rafael
    Shah, Tariq
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 592 - 593
  • [2] Alemtuzumab Induction Therapy in Elderly Kidney Transplant Recipients.
    Yakubu, I.
    Masters, B.
    Ravichandran, B.
    Sparkes, T.
    Moss, M.
    Rasetto, F.
    Jonchhe, S.
    Thomas, B.
    Costa, N.
    Leeser, D.
    Bartlett, S.
    Haririan, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 613 - 614
  • [3] Evaluation of Survival and Maintenance Immunosuppression in Elderly Lung Transplant Recipients.
    Nguyen, P.
    Girgis, R.
    Murphy, E.
    Hadley, R.
    Leacche, M.
    Kumar, A.
    Sathiyamoorthy, G.
    McDermott, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 861 - 862
  • [4] Use of thymoglobulin for induction immunosuppression in living unrelated kidney transplant recipients.
    Wong, WC
    Agrawal, N
    Pascual, M
    DelVecchio, AM
    Doran, MT
    Anderson, D
    Hirsh, H
    Delmonico, FL
    Cosimi, AB
    Tolkoff-Rubin, N
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 442A - 442A
  • [5] Alemtuzumab Induction is Effective and Safe in Elderly Kidney Transplant Recipients.
    Toledo, A.
    Szempruch, K.
    Serrano, P.
    Andreoni, K.
    Kozlowski, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 678 - 678
  • [6] Frailty, Immunosuppression Tolerance, and Outcomes in Kidney Transplant Recipients.
    McAdams-DeMarco, M.
    Law, A.
    King, B.
    Walston, J.
    Segev, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 619 - 619
  • [7] Frailty, Immunosuppression Tolerance, and Outcomes in Kidney Transplant Recipients.
    McAdams-DeMarco, M.
    Law, A.
    King, B.
    Walston, J.
    Segev, D.
    TRANSPLANTATION, 2014, 98 : 619 - 619
  • [8] Alemtuzumab versus Antithymocyte Globulin Induction Immunosuppression in Highly Sensitized Kidney Transplant Recipients.
    Brueckner, A.
    Yanqui, E.
    Truong, C.
    Baliga, R.
    Bowman, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 823 - 823
  • [9] A Financial Analysis of Elderly Kidney Transplant Recipients.
    Yaldo, A.
    Bajjoka, I.
    Crombez, C.
    Abouljoud, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 1107 - 1107
  • [10] Longitudinal evaluation of dd-cfDNA in elderly kidney transplant recipients.
    Samra, Manpreet
    Trotter, Christine
    Mahoney, Erin
    Mattes, Daine
    Cotiguala, Laura
    Thorndyke, Anne
    Patel, Shree
    Fu, Dennis
    Lopez-Soler, Reynold
    TRANSPLANTATION, 2024, 108 (09) : 447 - 448
12345